Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Allan Zimet"'
Autor:
Joanne Lundy, Marion Harris, John Zalcberg, Allan Zimet, David Goldstein, Val Gebski, Adina Borsaru, Christopher Desmond, Michael Swan, Brendan J. Jenkins, Daniel Croagh
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundPancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer death and lacks effective treatment options. Diagnostic endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) biopsies represent an appealing source of material fo
Externí odkaz:
https://doaj.org/article/ac6b0e5a24c74eb78ba029637dd2e93f
Autor:
Ali Bazargan, Julian Lindsay, Robert Twigger, Ashleigh P Scott, Judith Trotman, Carrie van der Weyden, Lindsay Dunlop, Hang Quach, Luke Coyle, Minh Hua, Lorenz Admojo, Glen A Kennedy, Susan Moreton, Naadir Gutta, Ian Irving, Michael Dickinson, David Kipp, Shyam Panicker, Andrew McQuillan, Sam Yuen, Mansi Bhurani, Pratyush Giri, Christopher McCormack, Allan Zimet, Henry Miles Prince, Dejan Radeski, Eliza A Hawkes, Liane Khoo, James Yeung
Publikováno v:
Leukemialymphoma. 62(2)
We present a retrospective multicenter study of pralatrexate treatment outcomes in an Australian practice setting for patients with relapsed/refractory T-cell lymphoma who had failed 1+ systemic therapies, treated via a compassionate access program.
Autor:
Natalie Heather, Turner, Hui-Li, Wong, Kathryn, Field, Rachel, Wong, Jeremy, Shapiro, Desmond, Yip, Louise, Nott, Jeanne, Tie, Suzanne, Kosmider, Ben, Tran, Jayesh, Desai, Joseph, McKendrick, Allan, Zimet, Gary, Richardson, Mahesh, Iddawela, Peter, Gibbs
Publikováno v:
Asia-Pacific journal of clinical oncology. 11(3)
Defining multidisciplinary quality of care indicators (QCIs) for metastatic colorectal cancer (mCRC) could improve understanding of variations in routine practice care. This may identify areas of below-average performance, which could then be address
Autor:
Michael, Michael, Shane C, White, Ehtesham, Abdi, Louise, Nott, Phillip, Clingan, Allan, Zimet, Peter, Button, Daniel, Gregory, Benjamin, Solomon, Alexander, Dobrovic, Hongdo, Do, Stephen, Clarke
Publikováno v:
Asia-Pacific journal of clinical oncology. 11(1)
The potential beneficial interaction between erlotinib and chemotherapy may require sequencing or pharmacodynamic separation. The aim of this study was to evaluate the efficacy and tolerance of sequential erlotinib and gemcitabine versus gemcitabine